You have 9 free searches left this month | for more free features.
Clincosm LogoSign in Get a demo

Anaplastic astrocytomas

Showing 1 - 25 of 318
STUDY
CONDITIONS
INTERVENTIONS
LOCATIONS
LAST UPDATED

Glioblastoma Multiforme, Anaplastic Astrocytoma, Fibrillary Astrocytomas Trial in Miami (SIACI of cetuximab and bevacizumab)

Not yet recruiting
  • Glioblastoma Multiforme
  • +4 more
  • SIACI of cetuximab and bevacizumab
  • Miami, Florida
    Jackson Memorial Hospital
Jul 14, 2023

High Grade Glioma Trial in San Francisco (nanoliposomal irinotecan)

Active, not recruiting
  • High Grade Glioma
  • nanoliposomal irinotecan
  • San Francisco, California
    University of California, San Francisco
Oct 26, 2021

Pilomyxoid Astrocytoma, Pilocytic Astrocytoma, Glioma, Astrocytic Trial in New Hyde Park (Mebendazole, Vincristine, Carboplatin)

Recruiting
  • Pilomyxoid Astrocytoma
  • +11 more
  • New Hyde Park, New York
    Cohen Children's Medical Center of New York
Mar 3, 2021

Astrocytoma Trial (Vorasidenib, Pembrolizumab)

Not yet recruiting
  • Astrocytoma
  • (no location specified)
Aug 1, 2022

Neurofibromatosis Type 1, Recurrent Childhood Pilocytic Astrocytoma, Recurrent Childhood Visual Pathway Glioma Trial in

Active, not recruiting
Has Results
  • Neurofibromatosis Type 1
  • +2 more
  • Birmingham, Alabama
  • +125 more
Jan 25, 2023

Trends in Anaplastic Thyroid Cancer Patients' Clinical Study

Not yet recruiting
  • Anaplastic Thyroid Cancer
    • (no location specified)
    Apr 6, 2023

    Lung Cancer, NSCLC Trial (Lorlatinib, Cisplatin or Carboplatin, Pemetrexed)

    Not yet recruiting
    • Lung Cancer
    • Non-small Cell Lung Cancer
    • (no location specified)
    Jul 7, 2023

    Frameshift Peptides of Children With NF1

    Completed
    • Neurofibromatosis Type 1
    • Frameshift Array blood sample test
    • Washington, District of Columbia
    • +2 more
    Aug 29, 2022

    Anaplastic Thyroid Cancer Trial in Japan (Lenvatinib, Nivolumab)

    Recruiting
    • Anaplastic Thyroid Cancer
    • Nagoya, Aichi, Japan
    • +9 more
    Jan 13, 2023

    Thyroid Cancer, Anaplastic Thyroid Cancer, Undifferentiated Thyroid Cancer Trial in Stanford (Abemaciclib)

    Active, not recruiting
    • Thyroid Cancer
    • +2 more
    • Stanford, California
      Stanford University
    Nov 8, 2022

    Thyroid Cancer Trial in Chengdu (Tislelizumab, Anlotinib, Radiotherapy)

    Recruiting
    • Thyroid Cancer
    • Chengdu, Sichuan, China
      Xingchen Peng
    Dec 17, 2022

    Juvenile Pilocytic Astrocytomas, Optic Pathway Gliomas Trial in Atlanta (Pegylated interferon alpha-2b)

    Completed
    Has Results
    • Juvenile Pilocytic Astrocytomas
    • Optic Pathway Gliomas
    • Pegylated interferon alpha-2b
    • Atlanta, Georgia
      Children's Healthcare of Atlanta
    Jan 18, 2022

    Thyroid Cancer Trial in United States (Avutometinib, Defactinib)

    Recruiting
    • Thyroid Cancer
    • Basking Ridge, New Jersey
    • +6 more
    Aug 17, 2023

    NSCLC Trial in Germany (Brigatinib, Tyrosine kinase inhibitor)

    Recruiting
    • NSCLC
    • Berlin, Germany
    • +25 more
    Nov 10, 2022

    Thyroid Cancer Trial (20 mg Famitinib & 1200 mg Adebrelimab)

    Not yet recruiting
    • Thyroid Cancer
    • 20 mg Famitinib & 1200 mg Adebrelimab
    • (no location specified)
    Nov 26, 2023

    IDH Family Wildtype, Recurrent Anaplastic Astrocytoma, Recurrent Glioblastoma Trial in Houston (Laser Interstitial Thermal

    Terminated
    Has Results
    • IDH Family Wildtype
    • +2 more
    • Houston, Texas
      M D Anderson Cancer Center
    Jul 14, 2022

    Thyroid Gland Anaplastic Carcinoma, Thyroid Gland Squamous Cell Carcinoma Trial in Houston, Salt Lake City (procedure, drug,

    Recruiting
    • Thyroid Gland Anaplastic Carcinoma
    • Thyroid Gland Squamous Cell Carcinoma
    • Conventional Surgery
    • +5 more
    • Stanford, California
    • +5 more
    Jan 26, 2023

    Tumors, Colorectal Tumors, Melanoma Trial in United States (Alectinib)

    Terminated
    • Neoplasms
    • +27 more
    • Culver City, California
    • +28 more
    Jul 25, 2022

    Astrocytoma, IDH-Mutant, Grade 2, Astrocytoma, IDH-Mutant, Grade 3 Trial in United States (other, radiation, drug)

    Active, not recruiting
    • Astrocytoma, IDH-Mutant, Grade 2
    • Astrocytoma, IDH-Mutant, Grade 3
    • Questionnaire Administration
    • +3 more
    • Phoenix, Arizona
    • +24 more
    Dec 7, 2022

    Lymphoma Trial in Worldwide (cyclophosphamide, cytarabine, dexamethasone)

    Completed
    • Lymphoma
    • Vienna, Austria
    • +9 more
    May 24, 2022

    Non Small Cell Lung Carcinoma NSCLC Trial in Worldwide (Durvalumab +Tremelimumab, Paclitaxel + carboplatin, Gemcitabine +

    Active, not recruiting
    Has Results
    • Non Small Cell Lung Carcinoma NSCLC
    • Durvalumab +Tremelimumab
    • +5 more
    • Anaheim, California
    • +210 more
    Jan 4, 2023

    NSCLC, ALK Gene Rearrangement Positive Trial in United States (Ensartinib)

    Available
    • Non-Small Cell Lung Cancer
    • ALK Gene Rearrangement Positive
    • Stanford, California
    • +3 more
    Oct 18, 2022

    Anaplastic Thyroid Cancer, Thyroid Cancer, BRAF Gene Mutation Trial in United States (Dabrafenib, Trametinib)

    Recruiting
    • Anaplastic Thyroid Cancer
    • +3 more
    • Basking Ridge, New Jersey
    • +6 more
    Jul 1, 2022

    Non Small Cell Lung Carcinoma NSCLC Trial in Worldwide (Durvalumab (MEDI4736), Paclitaxel + carboplatin, Gemcitabine +

    Active, not recruiting
    • Non Small Cell Lung Carcinoma NSCLC
    • Durvalumab (MEDI4736)
    • +5 more
    • Anaheim, California
    • +92 more
    Jan 31, 2023

    3T MRI of Intramedullary Spinal Cord Tumours

    Recruiting
    • Spinal Cord Tumor of Cervical Spine
    • MRI scan
    • Oxford, Oxfordshire, United Kingdom
      John Radcliffe Hospital
    Dec 15, 2022